← Back to Search

Behavioral Intervention

CBT-I for Insomnia

N/A
Waitlist Available
Research Sponsored by University of Pennsylvania
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months post-treatment (week 20 on average)
Awards & highlights

Study Summary

This trial will study changes in metabolism and depression symptoms in people with insomnia and MDD after receiving CBT-I.

Eligible Conditions
  • Insomnia
  • Primary Insomnia
  • Chronic Insomnia
  • Depression

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months post-treatment (week 20 on average)
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months post-treatment (week 20 on average) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Sleeplessness
Metabolomic Assays

Trial Design

2Treatment groups
Active Control
Group I: CBT-IActive Control1 Intervention
Group II: Waitlist ControlActive Control1 Intervention

Find a Location

Who is running the clinical trial?

University of PennsylvaniaLead Sponsor
2,002 Previous Clinical Trials
42,880,989 Total Patients Enrolled
15 Trials studying Insomnia
4,606 Patients Enrolled for Insomnia
Doris Duke Charitable FoundationOTHER
61 Previous Clinical Trials
260,076 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is it permissible for octogenarians to participate in this survey?

"This particular medical trial is only open to individuals aged 21-60. Conversely, there are 214 trials for those younger than 18 and 1127 that accept patients above the age of 65."

Answered by AI

Does my health profile match the criteria to be accepted into this medical experiment?

"For this experiment, the researchers are seeking 30 participants aged 21-60 who suffer from depression and insomnia. Additionally, they must meet diagnostic criteria for both major depressive disorder and insomnia (ISI > 14), as well as either being on a SSRI/SNRI or not taking any antidepressants."

Answered by AI
~2 spots leftby Apr 2025